EDSA - Edesa Biotech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
34.82M
Enterprise Value 3
28.16M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
69,641.48
Price/Book (mrq)
5.60
Enterprise Value/Revenue 3
56,314.91
Enterprise Value/EBITDA 6
-10.73

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-33.91%
S&P500 52-Week Change 318.39%
52 Week High 317.4000
52 Week Low 33.2800
50-Day Moving Average 35.1744
200-Day Moving Average 35.4620

Share Statistics

Avg Vol (3 month) 355.55k
Avg Vol (10 day) 311.67k
Shares Outstanding 57.5M
Float 1.55M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Nov 15, 2019) 43.86k
Short Ratio (Nov 15, 2019) 40.12
Short % of Float (Nov 15, 2019) 40.14%
Short % of Shares Outstanding (Nov 15, 2019) 40.05%
Shares Short (prior month Oct 15, 2019) 49.68k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jun 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-525,297.17%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)500
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -2.62M
Net Income Avi to Common (ttm)-2.53M
Diluted EPS (ttm)-5.7940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.36M
Total Cash Per Share (mrq)0.85
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.02
Book Value Per Share (mrq)0.83

Cash Flow Statement

Operating Cash Flow (ttm)-4.12M
Levered Free Cash Flow (ttm)N/A